NCT01728298View on ClinicalTrials.gov

A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Allergic Rhinitis
Interventions
BIOLOGICAL

SLITone ULTRA HDM immunotherapy

Trial Locations (1)

31059

Proffesor Alain Didier, Toulouse

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT01728298 - A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy | Biotech Hunter | Biotech Hunter